Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes

doi:10.1007/s13238-015-0142-8

Protein Cell

2015, Vol. 6

Issue (8) : 575-588 https://doi.org/10.1007/s13238-015-0142-8

RESEARCH ARTICLE

Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes

Lin Lin¹,Qingqing Cai^1,³,Xiaoyan Zhang⁵,Hongwei Zhang¹,Yang Zhong^6,⁷,Congjian Xu^1,^2,^3,^4,^*(

),Yanyun Li^1,^*(

)

1. Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai 200011, China
2. Department of Obstetrics and Gynecology of Shanghai Medical School, Fudan University, Shanghai 200032, China
3. Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai 200011, China
4. Institute of Biomedical Sciences, Fudan University, Shanghai 200032, China
5. School of Life Sciences and Technology, Tongji University, Shanghai 200092, China
6. Shanghai Center for Bioinformation Technology, Shanghai 200235, China
7. School of Life Sciences, Fudan University, Shanghai 200433, China

Download: PDF(2351 KB)
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Human papillomaviruses (HPVs) including high-risk (HR) and low-risk (LR) subtypes have distinguishable variation on both genotypes and phenotypes. The coinfection of multiple HR-HPVs, headed by HPV16, is common in cervical cancer in female. Recently accumulating reports have focused on the interaction between virus and host, particularly the role of human microRNAs (miRNAs) in anti-viral defense by targeting viral genome. Here, we found a well-conserved target site of miRNAs in the genomes of most HR-HPVs, not LR-HPVs, by scanning all potential target sites of human miRNAs on 24 HPVs of unambiguous subtypes of risk. The site is targeted by two less common human miRNAs, miR-875 and miR-3144, and is located in E6 oncogene open reading frame (ORF) and overlap with the first alternative splice exon of viral early transcripts. In validation tests, miR-875 and miR-3144 were identified to suppress the target reporter activity markedly and inhibit the expression of both synthetically exogenous E6 and endogenous E6 oncogene. High level of two miRNAs can inhibit cell growth and promote apoptosis in HPV16-positive cervical cancer cells. This study provides a promising common target of miRNAs for most HR-HPVs and highlights the effects of two low expressed human miRNAs on tumour suppression.

Keywords human papillomavirus microRNA E6 miR-875 miR-3144

Corresponding Author(s): Congjian Xu,Yanyun Li

Issue Date: 05 August 2015

Cite this article:

Lin Lin,Qingqing Cai,Xiaoyan Zhang, et al. Two less common human microRNAs miR-875 and miR-3144 target a conserved site of E6 oncogene in most high-risk human papillomavirus subtypes[J]. Protein Cell, 2015, 6(8): 575-588.

URL:

https://academic.hep.com.cn/pac/EN/10.1007/s13238-015-0142-8
https://academic.hep.com.cn/pac/EN/Y2015/V6/I8/575

1	Alp Avci G (2012) Genomic organization and proteins of human papillomavirus. Mikrobiyol bul 46: 507-515
2	Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355 https://doi.org/10.1038/nature02871
3	Bentwich I (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910 https://doi.org/10.1016/j.febslet.2005.09.040
4	Bernard HU, Burk RD, Chen Z, van Doorslaer K, zur Hausen H, de Villiers EM(2010) Classification of papillomaviruses (PVs) basedon 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79 https://doi.org/10.1016/j.virol.2010.02.002
5	Chan LW, Wang FF, Cho WC (2012) Genomic sequence analysis of EGFR regulation by microRNAs in lung cancer. Curr Top Med Chem 12: 920-926 https://doi.org/10.2174/156802612800166747
6	de Freitas AC, Coimbra EC, Leitao Mda C (2014) Molecular targets of HPV oncoproteins: potential biomarkers for cervical carcinogenesis. Biochim Biophys Acta 1845: 91-103 https://doi.org/10.1016/j.bbcan.2013.12.004
7	del Moral-Hernandez O, Lopez-Urrutia E, Bonilla-Moreno R, Martinez-Salazar M, Arechaga-Ocampo E, Berumen J, Villegas-Sepulveda N (2010) The HPV-16 E7 oncoprotein is expressed mainly from the unspliced E6/E7 transcript in cervical carcinoma C33-A cells. Arch Virol 155: 1959-1970 https://doi.org/10.1007/s00705-010-0787-9
8	Dreher A, Rossing M, Kaczkowski B, Andersen DK, Larsen TJ, Christophersen MK, Nielsen FC, Norrild B (2011) Differential expression of cellular microRNAs in HPV 11, -16, and-45 transfected cells. Biochem Biophys Res Commun 412: 20-25 https://doi.org/10.1016/j.bbrc.2011.07.011
9	Filippova M, Johnson MM, Bautista M, Filippov V, Fodor N, Tungteakkhun SS, Williams K, Duerksen-Hughes PJ (2007) The large and small isoforms of human papillomavirus type 16 E6 bind to and differentially affect procaspase 8 stability and activity. J Virol 81: 4116-4129 https://doi.org/10.1128/JVI.01924-06
10	Forman JJ, Coller HA (2010) The code within the code: microRNAs target coding regions. Cell Cycle 9: 1533-1541 https://doi.org/10.4161/cc.9.8.11202
11	Ghosh Z, Mallick B, Chakrabarti J (2009) Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 37: 1035-1048 https://doi.org/10.1093/nar/gkn1004
12	Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P, Auvinen E (2011) Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 6: e21646 https://doi.org/10.1371/journal.pone.0021646
13	Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for microRNA genomics. Nucleic Acids Res 36: D154-D158 https://doi.org/10.1093/nar/gkm952
14	Gunasekharan V, Laimins LA (2013) Human papillomaviruses modulate microRNA 145 expression to directly control genome amplification. J Virol 87: 6037-6043 https://doi.org/10.1128/JVI.00153-13
15	Hamfjord J, Stangeland AM, Hughes T, Skrede ML, Tveit KM, Ikdahl T, Kure EH (2012) Differential expression of miRNAs in colorectal cancer: comparison of paired tumor tissue and adjacent normal mucosa using high-throughput sequencing. PLoS One 7: e34150 https://doi.org/10.1371/journal.pone.0034150
16	Hao J, Zhang S, Zhou Y, Hu X, Shao C (2011) MicroRNA 483-3p suppresses the expression of DPC4/Smad4 in pancreatic cancer. FEBS Lett 585: 207-213 https://doi.org/10.1016/j.febslet.2010.11.039
17	Harper DM, Demars LR (2014) Primary strategies for HPV infection and cervical cancer prevention. Clin Obstet Gynecol 57: 256-278 https://doi.org/10.1097/GRF.0000000000000027
18	Hayes J, Peruzzi PP, Lawler S (2014) MicroRNAs in cancer: biomarkers, functions and therapy. Trends Mol Med 20: 460-469 https://doi.org/10.1016/j.molmed.2014.06.005
19	Hernandez-Lopez HR, Graham SV (2012) Alternative splicing in human tumour viruses: a therapeutic target? Biochem J 445: 145-156
20	Houzet L, Klase Z, Yeung ML, Wu A, Le SY, Quinones M, Jeang KT (2012) The extent of sequence complementarity correlates with the potency of cellular miRNA-mediated restriction of HIV-1. Nucleic Acids Res 40: 11684-11696 https://doi.org/10.1093/nar/gks912
21	Jimenez-Wences H, Peralta-Zaragoza O, Fernandez-Tilapa G (2014) Human papilloma virus, DNA methylation and microRNA expression in cervical cancer (Review). Oncol Rep 31: 2467-2476
22	John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human microRNA targets. PLoS Biol 2: e363 https://doi.org/10.1371/journal.pbio.0020363
23	Juan Moran GR, Uribe-Boll Jimena, Cruz Alfredo, Jimenez Luis, Banales Jose-Luis, Romero Sandra, Hidalgo Alfredo, Bautista Edgar, Merino Enrique, Zuniga Joaquin (2014) Circulating microRNA profiles in patients with severe pneumonia associated to the A/H1N1 virus. Am J Respir Crit Care Med 189: A2694
24	Jung HM, Phillips BL, Chan EK (2014) miR-375 activates p21 and suppresses telomerase activity by coordinately regulating HPV E6/E7, E6AP, CIP2A, and 14-3-3zeta. Mol Cancer 13: 80 https://doi.org/10.1186/1476-4598-13-80
25	Kuhn DE, Martin MM, Feldman DS, Terry AV Jr, Nuovo GJ, Elton TS (2008) Experimental validation of miRNA targets. Methods 44: 47-54 https://doi.org/10.1016/j.ymeth.2007.09.005
26	Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M (2007) A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129: 1401-1414 https://doi.org/10.1016/j.cell.2007.04.040
27	Lecellier CH, Dunoyer P, Arar K, Lehmann-Che J, Eyquem S, Himber C, Saib A, Voinnet O (2005) A cellular microRNA mediates antiviral defense in human cells. Science 308: 557-560 https://doi.org/10.1126/science.1108784
28	Li Y, Li Z, He Y, Kang Y, Zhang X, Cheng M, Zhong Y, Xu C (2009) Phylogeographic analysis of human papillomavirus 58. Sci China Ser C 52: 1164-1172 https://doi.org/10.1007/s11427-009-0149-6
29	Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J (2011) MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR. Proc Natl Acad Sci U S Am 108: 4991-4996 https://doi.org/10.1073/pnas.1016606108
30	Li L, Chen HZ, Chen FF, Li F, Wang M, Wang L, Li YQ, Gao DS (2013) Global microRNA expression profiling reveals differential expression of target genes in 6-hydroxydopamine-injured MN9D cells. Neuromol Med 15: 593-604 https://doi.org/10.1007/s12017-013-8244-z
31	Mahajan VS, Drake A, Chen J (2009) Virus-specific host miRNAs: antiviral defenses or promoters of persistent infection? Trends Immunol 30: 1-7 https://doi.org/10.1016/j.it.2008.08.009
32	Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, Khan SA (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582 https://doi.org/10.1038/sj.onc.1210919
33	Mejlhede N, Pedersen BV, Frisch M, Fomsgaard A (2010) Multiple human papilloma virus types in cervical infections: competition or synergy? APMIS 118: 346-352 https://doi.org/10.1111/j.1600-0463.2010.2602.x
34	Melar-New M, Laimins LA (2010) Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins. J Virol 84: 5212-5221 https://doi.org/10.1128/JVI.00078-10
35	Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ, International Agency for Research on Cancer Multicenter Cervical Cancer Study, G (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527 https://doi.org/10.1056/NEJMoa021641
36	Nguyen HC, Xie W, Yang M, Hsieh CL, Drouin S, Lee GS, Kantoff PW (2013) Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate 73: 346-354 https://doi.org/10.1002/pros.22572
37	Nuovo GJ, Wu X, Volinia S, Yan F, di Leva G, Chin N, Nicol AF, Jiang J, Otterson G, Schmittgen TD (2010) Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagn Mol Pathol 19: 135-143 https://doi.org/10.1097/PDM.0b013e3181c4daaa
38	Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M (2007) Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449: 919-922 https://doi.org/10.1038/nature06205
39	Pim D, Banks L (1999) HPV-18 E6*I protein modulates the E6-directed degradation of p53 by binding to full-length HPV-18 E6. Oncogene 18: 7403-7408 https://doi.org/10.1038/sj.onc.1203134
40	Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A (2011) Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39: 5157-5163 https://doi.org/10.1093/nar/gkr067
41	Qian K, Pietila T, Ronty M, Michon F, Frilander MJ, Ritari J, Tarkkanen J, Paulin L, Auvinen P, Auvinen E (2013) Identification and validation of human papillomavirus encoded microRNAs. PLoS One 8: e70202 https://doi.org/10.1371/journal.pone.0070202
42	Qingqing Cai X.Z, Zoufeng Li (2010) MiRNAs as promising phylogenetic markers for inferring deep metazoan phylogeny and in support of Olfactores hypothesis. Bioinformatics and Biomedicine (BIBM), 2010 IEEE International Conference on 18-21 Dec 2010, Hong Kong, 101-104
43	Rosenberger S, De-Castro Arce J, Langbein L, Steenbergen RD, Rosl F (2010) Alternative splicing of human papillomavirus type- 16 E6/E6* early mRNA is coupled to EGF signaling via Erk1/2 activation. Proc Natl Acad Sci U S A 107: 7006-7011 https://doi.org/10.1073/pnas.1002620107
44	Russo A, Potenza N (2011) Antiviral effects of human microRNAs and conservation of their target sites. FEBS lett 585: 2551-2555 https://doi.org/10.1016/j.febslet.2011.07.015
45	Scaria V, Hariharan M, Maiti S, Pillai B, Brahmachari SK (2006) Host-virus interaction: a new role for microRNAs. Retrovirology 3: 68 https://doi.org/10.1186/1742-4690-3-68
46	Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136 https://doi.org/10.1016/0092-8674(90)90409-8
47	Shi M, Du L, Liu D, Qian L, Hu M, Yu M, Yang Z, Zhao M, Chen C, Guo L (2012) Glucocorticoid regulation of a novel HPV-E6- p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells. J Pathol 228: 148-157 https://doi.org/10.1002/path.3997
48	Song L, Liu H, Gao S, Jiang W, Huang W (2010) Cellular microRNAs inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 84: 8849-8860 https://doi.org/10.1128/JVI.00456-10
49	Stacey SN, Jordan D, Snijders PJ, Mackett M, Walboomers JM, Arrand JR (1995) Translation of the human papillomavirus type 16 E7 oncoprotein from bicistronic mRNA is independent of splicing events within the E6 open reading frame. J Virol 69: 7023-7031
50	Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC, Parsons PG, Schmidt C, Sturm RA, Hayward NK (2010) Characterization of the melanoma miRNAome by deep sequencing. PloS One 5: e9685 https://doi.org/10.1371/journal.pone.0009685
51	Stewart BW, Wild CP (2014) World cancer report. IARC Scientific Publications, New Delhi
52	Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI (2000) Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60: 5916-5921
53	Weng L, Wu X, Gao H, Mu B, Li X, Wang JH, Guo C, Jin JM, Chen Z, Covarrubias M (2010) MicroRNA profiling of clear cell renal cell carcinoma by whole-genome small RNA deep sequencing of paired frozen and formalin-fixed, paraffin-embedded tissue specimens. J Pathol 222: 41-51 https://doi.org/10.1002/path.2736
54	Witten D, Tibshirani R, Gu SG, Fire A, Lui WO (2010) Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 8: 58 https://doi.org/10.1186/1741-7007-8-58
55	Zaravinos A, Lambrou GI, Mourmouras N, Katafygiotis P, Papagregoriou G, Giannikou K, Delakas D, Deltas C (2014) New miRNA profiles accurately distinguish renal cell carcinomas and upper tract urothelial carcinomas from the normal kidney. PLoS One 9: e91646 https://doi.org/10.1371/journal.pone.0091646
56	Zhao X, Liu Q, Cai Q, Li Y, Xu C, Li Z, Zhang X (2012) Dr.VIS: a database of human disease-related viral integration sites. Nucleic Acids Res 40: D1041-D1046 https://doi.org/10.1093/nar/gkr1142
57	Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302 https://doi.org/10.2741/1971
58	Zheng ZM, Wang X (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 1809: 668-677 https://doi.org/10.1016/j.bbagrm.2011.05.005
59	zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350 https://doi.org/10.1038/nrc798

[1]	Xi Chen, Lin Wang, Rujin Huang, Hui Qiu, Peizhe Wang, Daren Wu, Yonglin Zhu, Jia Ming, Yangming Wang, Jianbin Wang, Jie Na. Dgcr8 deletion in the primitive heart uncovered novel microRNA regulating the balance of cardiac-vascular gene program[J]. Protein Cell, 2019, 10(5): 327-346.
[2]	Na Qu, Zhao Ma, Mengrao Zhang, Muaz N. Rushdi, Christopher J. Krueger, Antony K. Chen. Inhibition of retroviral Gag assembly by non-silencing miRNAs promotes autophagic viral degradation[J]. Protein Cell, 2018, 9(7): 640-651.
[3]	Yuanyuan Gu, Shuoxin Liu, Xiaodan Zhang, Guimin Chen, Hongwei Liang, Mengchao Yu, Zhicong Liao, Yong Zhou, Chen-Yu Zhang, Tao Wang, Chen Wang, Junfeng Zhang, Xi Chen. Oncogenic miR-19a and miR-19b co-regulate tumor suppressor MTUS1 to promote cell proliferation and migration in lung cancer[J]. Protein Cell, 2017, 8(6): 455-466.
[4]	Shaohong Chen, Guangxia Gao. MicroRNAs recruit eIF4E2 to repress translation of target mRNAs[J]. Protein Cell, 2017, 8(10): 750-761.
[5]	Zhiju Zhao,Shu Li,Erwei Song,Suling Liu. The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells[J]. Protein Cell, 2016, 7(2): 89-99.
[6]	Qian Fan,Xiangrui Meng,Hongwei Liang,Huilai Zhang,Xianming Liu,Lanfang Li,Wei Li,Wu Sun,Haiyang Zhang,Ke Zen,Chen-Yu Zhang,Zhen Zhou,Xi Chen,Yi Ba. miR-10a inhibits cell proliferation and promotes cell apoptosis by targeting BCL6 in diffuse large B-cell lymphoma[J]. Protein Cell, 2016, 7(12): 899-912.
[7]	Yanqing Liu,Uzair-ur-Rehman,Yu Guo,Hongwei Liang,Rongjie Cheng,Fei Yang,Yeting Hong,Chihao Zhao,Minghui Liu,Mengchao Yu,Xinyan Zhou,Kai Yin,Jiangning Chen,Junfeng Zhang,Chen-Yu Zhang,Feng Zhi,Xi Chen. miR-181b functions as an oncomiR in colorectal cancer by targeting PDCD4[J]. Protein Cell, 2016, 7(10): 722-734.
[8]	Hongwei Liang, Junfeng Zhang, Ke Zen, Chen-Yu Zhang, Xi Chen. Nuclear microRNAs and their unconventional role in regulating non-coding RNAs[J]. Prot Cell, 2013, 4(5): 325-330.
[9]	Yongkui Li, Jiajia Xie, Xiupeng Xu, Jun Wang, Fang Ao, Yushun Wan, Ying Zhu. MicroRNA-548 down-regulates host antiviral response via direct targeting of IFN-λ1[J]. Prot Cell, 2013, 4(2): 130-141.
[10]	Ya-Feng Li, Ying Jing, Jielu Hao, Nathan C Frankfort, Xiaoshuang Zhou, Bing Shen, Xinyan Liu, Lihua Wang, Rongshan Li. MicroRNA-21 in the pathogenesis of acute kidney injury[J]. Prot Cell, 2013, 4(11): 813-819.
[11]	Yifan Zhan, Li Wu. Functional regulation of monocyte-derived dendritic cells by microRNAs[J]. Prot Cell, 2012, 3(7): 497-507.
[12]	Munish Kumar, Sayantan Nath, Himanshu K Prasad, G D Sharma, Yong Li. MicroRNAs: a new ray of hope for diabetes mellitus[J]. Prot Cell, 2012, 3(10): 726-738.
[13]	Xi Chen, Hongwei Liang, Junfeng Zhang, Ke Zen, Chen-Yu Zhang. Horizontal transfer of microRNAs: molecular mechanisms and clinical applications[J]. Prot Cell, 2012, 3(1): 28-37.
[14]	Yong Huang, Quan Zou, Haitai Song, Fei Song, Ligang Wang, Guozheng Zhang, Xingjia Shen. A study of miRNAs targets prediction and experimental validation[J]. Prot Cell, 2010, 1(11): 979-986.
[15]	Shenglin Huang, Xianghuo He. microRNAs: tiny RNA molecules, huge driving forces to move the cell[J]. Prot Cell, 2010, 1(10): 916-926.

Viewed

Full text

Abstract

Cited

Shared

Discussed